The global Bare Metal Stents Market Study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments including By Product (Balloon Catheter, Self-Expendable, Metallic Stent, Balloon Expendable Stent), By End-User (Hospitals, Ambulatory Surgical Centers, Cardiac Catheterization Laboratories).
The Bare Metal Stents Market focuses on medical devices used in interventional cardiology and vascular procedures to restore blood flow, support vessel patency, and treat coronary artery disease (CAD) and peripheral arterial disease (PAD). In 2024, bare metal stents (BMS) provide mechanical scaffolding, plaque stabilization, and vascular revascularization, serving as alternatives to drug-eluting stents (DES) for patients with stenotic lesions and atherosclerotic blockages. With considerations for stent design, biocompatibility, and restenosis prevention, the bare metal stents market supports cardiovascular interventions, revascularization strategies, and coronary artery treatments for patients with ischemic heart disease.
The global Bare Metal Stents Industry is highly competitive with a large number of companies focusing on niche market segments. Amidst intense competitive conditions, Bare Metal Stents Companies are investing in new product launches and strengthening distribution channels. Key companies operating in the Bare Metal Stents Industry include- Abbott Laboratories, AlviMedica, Amaranth Medical Inc, AMG International GmbH, Andramed GmbH, Arthesys, Biotronik SE & Co. KG, Boston SciTech Inc Minvasys, Cardinal Health, Comed B.V., Degania Silicone Ltd, Elixir Medical Corp, Endocor GmbH, Eurocor Tech GmbH, Hexacath, InSitu Technologies Inc, Inspire MD Inc, iVascular SLU, Lepu Medical and Translumina Therapeutics, Medinol Ltd, Medtronic Plc, Meril Life Sciences Pvt. Ltd, MicroPort Scientific Corp, Orbusneich Medical, Stentys SA, Terumo Corp.
The market for bare metal stents is witnessing a significant trend characterized by the transition towards drug-eluting stents (DES). While bare metal stents have been widely used in coronary artery interventions, there is a growing preference for DES due to their ability to reduce the risk of restenosis and improve long-term clinical outcomes. DES are coated with pharmacological agents that inhibit neointimal hyperplasia and promote endothelialization, thereby reducing the incidence of in-stent restenosis and the need for repeat revascularization procedures. This trend reflects the continuous innovation in interventional cardiology and the pursuit of optimal treatment strategies to enhance patient care and minimize complications associated with coronary artery disease.
A key driver propelling the market for bare metal stents is the rising incidence of cardiovascular diseases (CVDs) and coronary artery disorders worldwide. Factors such as sedentary lifestyles, unhealthy dietary habits, tobacco use, and aging populations contribute to the increasing prevalence of coronary artery disease (CAD), myocardial infarction (MI), and other CVDs. As these conditions pose significant morbidity and mortality risks, there is a growing demand for effective treatment options to restore coronary blood flow, relieve symptoms, and improve cardiac function. Bare metal stents remain an essential therapeutic tool in the armamentarium of interventional cardiologists, offering immediate mechanical support and facilitating coronary artery revascularization in patients with acute coronary syndromes or obstructive CAD.
An emerging opportunity within the market for bare metal stents lies in the focus on bioresorbable scaffolds (BRS) and next-generation stent technologies. While DES have largely supplanted bare metal stents in many clinical scenarios, there is ongoing research and development efforts to enhance the performance and biocompatibility of metallic stents. Bioresorbable scaffolds represent a promising alternative to traditional stent platforms, as they provide temporary mechanical support to the vessel wall during the healing process and gradually degrade over time, potentially reducing the risk of late stent thrombosis and facilitating vascular restoration. Additionally, next-generation bare metal stents incorporating novel materials, surface coatings, and stent designs aim to improve deliverability, conformability, and biocompatibility while maintaining the mechanical advantages of metallic scaffolds. By investing in innovation, clinical validation, and regulatory approvals, medical device manufacturers can capitalize on the evolving landscape of interventional cardiology and address the evolving needs of patients and healthcare providers for safer and more effective coronary artery stent solutions.
Metallic stents have emerged as the fastest-growing segment among bare metal stents. These stents offer advantages such as durability and radial strength, making them preferred choices for coronary artery disease treatment. The growth in metallic stents can be attributed to advancements in stent design, including improved biocompatibility and reduced rates of restenosis. Additionally, the increasing prevalence of cardiovascular diseases and the rising demand for minimally invasive procedures in cardiac catheterization laboratories contribute to the rapid expansion of metallic stents in the market. With their ability to provide long-term vessel patency and lower rates of revascularization, metallic stents are increasingly favored by hospitals, ambulatory surgical centers, and cardiac catheterization laboratories for coronary interventions, thus driving their significant growth in the bare metal stent market.
By Product
Balloon Catheter
Self-Expendable
Metallic Stent
Balloon Expendable Stent
By End-User
Hospitals
Ambulatory Surgical Centers
Cardiac Catheterization Laboratories
Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)
Abbott Laboratories
AlviMedica
Amaranth Medical Inc
AMG International GmbH
Andramed GmbH
Arthesys
Biotronik SE & Co. KG
Boston SciTech Inc Minvasys
Cardinal Health
Comed B.V.
Degania Silicone Ltd
Elixir Medical Corp
Endocor GmbH
Eurocor Tech GmbH
Hexacath
InSitu Technologies Inc
Inspire MD Inc
iVascular SLU
Lepu Medical and Translumina Therapeutics
Medinol Ltd
Medtronic Plc
Meril Life Sciences Pvt. Ltd
MicroPort Scientific Corp
Orbusneich Medical
Stentys SA
Terumo Corp
* List not Exhaustive
• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the Bare Metal Stents Market, encompassing current market size, growth trends, and forecasts till 2030.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the Bare Metal Stents Industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.
TABLE OF CONTENTS
1 Introduction to 2024 Bare Metal Stents Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Analyzed
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain
2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations
3 Executive Summary
3.1 Global Bare Metal Stents Market Size Outlook, $ Million, 2021 to 2030
3.2 Bare Metal Stents Market Outlook by Type, $ Million, 2021 to 2030
3.3 Bare Metal Stents Market Outlook by Product, $ Million, 2021 to 2030
3.4 Bare Metal Stents Market Outlook by Application, $ Million, 2021 to 2030
3.5 Bare Metal Stents Market Outlook by Key Countries, $ Million, 2021 to 2030
4 Market Dynamics
4.1 Key Driving Forces of Bare Metal Stents Industry
4.2 Key Market Trends in Bare Metal Stents Industry
4.3 Potential Opportunities in Bare Metal Stents Industry
4.4 Key Challenges in Bare Metal Stents Industry
5 Market Factor Analysis
5.1 Value Chain Analysis
5.2 Competitive Landscape
5.2.1 Global Bare Metal Stents Market Share by Company (%), 2023
5.2.2 Product Offerings by Company
5.3 Porter’s Five Forces Analysis
5.4 Pricing Analysis and Outlook
6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts
7 Global Bare Metal Stents Market Outlook by Segments
7.1 Bare Metal Stents Market Outlook by Segments, $ Million, 2021- 2030
By Product
Balloon Catheter
Self-Expendable
Metallic Stent
Balloon Expendable Stent
By End-User
Hospitals
Ambulatory Surgical Centers
Cardiac Catheterization Laboratories
8 North America Bare Metal Stents Market Analysis and Outlook To 2030
8.1 Introduction to North America Bare Metal Stents Markets in 2024
8.2 North America Bare Metal Stents Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America Bare Metal Stents Market size Outlook by Segments, 2021-2030
By Product
Balloon Catheter
Self-Expendable
Metallic Stent
Balloon Expendable Stent
By End-User
Hospitals
Ambulatory Surgical Centers
Cardiac Catheterization Laboratories
9 Europe Bare Metal Stents Market Analysis and Outlook To 2030
9.1 Introduction to Europe Bare Metal Stents Markets in 2024
9.2 Europe Bare Metal Stents Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe Bare Metal Stents Market Size Outlook by Segments, 2021-2030
By Product
Balloon Catheter
Self-Expendable
Metallic Stent
Balloon Expendable Stent
By End-User
Hospitals
Ambulatory Surgical Centers
Cardiac Catheterization Laboratories
10 Asia Pacific Bare Metal Stents Market Analysis and Outlook To 2030
10.1 Introduction to Asia Pacific Bare Metal Stents Markets in 2024
10.2 Asia Pacific Bare Metal Stents Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific Bare Metal Stents Market size Outlook by Segments, 2021-2030
By Product
Balloon Catheter
Self-Expendable
Metallic Stent
Balloon Expendable Stent
By End-User
Hospitals
Ambulatory Surgical Centers
Cardiac Catheterization Laboratories
11 South America Bare Metal Stents Market Analysis and Outlook To 2030
11.1 Introduction to South America Bare Metal Stents Markets in 2024
11.2 South America Bare Metal Stents Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America Bare Metal Stents Market size Outlook by Segments, 2021-2030
By Product
Balloon Catheter
Self-Expendable
Metallic Stent
Balloon Expendable Stent
By End-User
Hospitals
Ambulatory Surgical Centers
Cardiac Catheterization Laboratories
12 Middle East and Africa Bare Metal Stents Market Analysis and Outlook To 2030
12.1 Introduction to Middle East and Africa Bare Metal Stents Markets in 2024
12.2 Middle East and Africa Bare Metal Stents Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa Bare Metal Stents Market size Outlook by Segments, 2021-2030
By Product
Balloon Catheter
Self-Expendable
Metallic Stent
Balloon Expendable Stent
By End-User
Hospitals
Ambulatory Surgical Centers
Cardiac Catheterization Laboratories
13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
Abbott Laboratories
AlviMedica
Amaranth Medical Inc
AMG International GmbH
Andramed GmbH
Arthesys
Biotronik SE & Co. KG
Boston SciTech Inc Minvasys
Cardinal Health
Comed B.V.
Degania Silicone Ltd
Elixir Medical Corp
Endocor GmbH
Eurocor Tech GmbH
Hexacath
InSitu Technologies Inc
Inspire MD Inc
iVascular SLU
Lepu Medical and Translumina Therapeutics
Medinol Ltd
Medtronic Plc
Meril Life Sciences Pvt. Ltd
MicroPort Scientific Corp
Orbusneich Medical
Stentys SA
Terumo Corp
14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise
By Product
Balloon Catheter
Self-Expendable
Metallic Stent
Balloon Expendable Stent
By End-User
Hospitals
Ambulatory Surgical Centers
Cardiac Catheterization Laboratories
The global Bare Metal Stents Market is one of the lucrative growth markets, poised to register a 1.8% growth (CAGR) between 2024 and 2030.
Emerging Markets across Asia Pacific, Europe, and Americas present robust growth prospects.
Abbott Laboratories, AlviMedica, Amaranth Medical Inc, AMG International GmbH, Andramed GmbH, Arthesys, Biotronik SE & Co. KG, Boston SciTech Inc Minvasys, Cardinal Health, Comed B.V., Degania Silicone Ltd, Elixir Medical Corp, Endocor GmbH, Eurocor Tech GmbH, Hexacath, InSitu Technologies Inc, Inspire MD Inc, iVascular SLU, Lepu Medical and Translumina Therapeutics, Medinol Ltd, Medtronic Plc, Meril Life Sciences Pvt. Ltd, MicroPort Scientific Corp, Orbusneich Medical, Stentys SA, Terumo Corp
Base Year- 2023; Estimated Year- 2024; Historic Period- 2018-2023; Forecast period- 2024 to 2030; Currency: USD; Volume